Anti-angiogenesis: A new potential strategy to inhibit restenosis

Author： Fuchs Shmuel   Kornowski Ran   Leon Martin B   Epstein Stephen E  

Publisher： Informa Healthcare

ISSN： 1471-1796

Source： International Journal of Cardiovascular Interventions, Vol.4, Iss.1, 2001-03, pp. : 3-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New anti-angiogenesis agents: review of the clinical experience with carboxyamido-triazole (CAI), thalidomide, TNP-470 and interleukin-12

By Masiero L.  

Angiogenesis, Vol. 1, Iss. 1, 1997-01 ,pp. : 23-35

Springer Publishing Company

Access to resources Recommend Favorite

Endostatin and angiostatin: the next anti-angiogenesis generation

By Kohn E.C.  

Angiogenesis, Vol. 2, Iss. 1, 1998-01 ,pp. : 25-27

Springer Publishing Company

Access to resources Recommend Favorite

Proteinuria and glomerular injury associated with the anti-angiogenesis drug Vargatef

By Manjunath Veena   Moeckel Gilbert W.   Mahnensmith Rex   Perazella Mark A.  

NDT PLUS, Vol. 4, Iss. 6, 2011-12 ,pp. : 430-433

Oxford University Press

Access to resources Recommend Favorite

Antiangiogenesis: New frontiers in therapeutic development

By LaMontagne Kenneth  

Angiogenesis, Vol. 8, Iss. 4, 2006-02 ,pp. : 285-287

Springer Publishing Company

Access to resources Recommend Favorite

Angiogenesis and the Growth Potential of Craniopharyngiomas

By Vidal Sergio   Scheithauer Bernd W.   Kovacs Kalman   Lloyd Ricardo V.  

Endocrine Pathology, Vol. 16, Iss. 3, 2005-09 ,pp. : 219-228

Humana Press, Inc

Access to resources Recommend Favorite